(Q42445185)

31 October 2017

Adenovirus-mediated interleukin-2 gene therapy of nociception (English)

1 reference

sensory perception of pain

31 October 2017

1 reference

1 reference

Yao MZ

1

1 reference

31 October 2017

Gu JF

2

1 reference

31 October 2017

Wang JH

3

1 reference

31 October 2017

Sun LY

4

1 reference

31 October 2017

Liu H

5

1 reference

31 October 2017

Liu XY

6

1 reference

31 October 2017

1 August 2003

1 reference

31 October 2017

1 reference

31 October 2017

10

1 reference

31 October 2017

1392-1399

1 reference

31 October 2017

16

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301992

31 October 2017

0 references

cites work

Interleukin-2 and its effects in the central nervous system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

Immunoautoradiographic localization of interleukin 2-like immunoreactivity and interleukin 2 receptors (Tac antigen-like immunoreactivity) in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

Interleukin 2-induced antinociception partially coupled with mu receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

Interleukin-2: structural and biological relatedness to opioid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

fMRI shows multiple somatotopic digit representations in human primary somatosensory cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

Interleukin-2 gene therapy of chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

Adenoviral gene transfer to spinal-cord neurons: intrathecal vs. intraparenchymal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

Morphine receptors as regulators of adenylate cyclase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

Co-localization of mu-opioid receptor-like and substance P-like immunoreactivities in axon terminals within the superficial layers of the medullary and spinal dorsal horns of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

21 January 2018

An improved MTT assay.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

Interleukin-2 as a neuroregulatory cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

7 January 2021

Expression of IL-2 receptor in dorsal root ganglion neurons and peripheral antinociception

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

7 January 2021

Interleukin 2 modifies the bioelectric activity of some neurosecretory nuclei in the rat hypothalamus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

7 January 2021

Human interleukin-2 could bind to opioid receptor and induce corresponding signal transduction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

7 January 2021

The analgesic domain of IL-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

7 January 2021

Inhibition of nociceptive withdrawal reflex by microinjection of interleukin 2 into rat locus coeruleus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

7 January 2021

Interleukin-2 gene has superior antinociceptive effects when delivered intrathecally

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

7 January 2021

Interleukin-2 modulates calcium currents in dissociated hippocampal CA1 neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

7 January 2021

Ultrastructural visualization of glutamate and aspartate immunoreactivities in the rat dorsal horn, with special reference to the co-localization of glutamate, substance P and calcitonin-gene related peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

7 January 2021

Lumbar catheterization of the spinal subarachnoid space in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

7 January 2021

A method for increasing the viability of the external portion of lumbar catheters placed in the spinal subarachnoid space of rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301992

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301992

1 reference

Dimensions Publication ID

31 October 2017

0 references

1 reference